Monge, Susana Guillot, Vicente Alvarez, Marta Chueca, Natalia Stella, Natalia Peña, Alejandro Delgado, Rafael Córdoba, Juan Aguilera, Antonio Vidal, Carmen García, Federico CoRIS Therapeutic barrier of first line ARV regimens using Stanford Algorithm. <p>* Threshold of the genotypic sensitivity score (GSS) used to consider the strain as resistant to a given ARV combination. TDF: tenofovir; ABC: abacavir; 3TC: lamivudine; FTC: emtricitabine; EFV: efavirenz; NVP: nevirapine; LPV: lopinavir; DRV: darunavir; ATZ: atazanavir.</p> biotechnology;Applied microbiology;microbiology;Medical microbiology;Microbial pathogens;Viral pathogens;Immunodeficiency viruses;hiv;Microbial control;antimicrobials;antivirals;Virology;Viral transmission and infection;Clinical medicine;health care;Health care policy;Screening guidelines;Treatment guidelines;Infectious diseases;Viral diseases;mathematics;Applied mathematics;algorithms;research design;Clinical research design;Cohort studies;arv;regimens;stanford 2014-03-17
    https://plos.figshare.com/articles/dataset/_Therapeutic_barrier_of_first_line_ARV_regimens_using_Stanford_Algorithm_/964031
10.1371/journal.pone.0090710.t003